SIMPHS 1- Strategic Intelligence Monitor on Personal Health Systems

  back to the eHealth main page

The SIMPHS 1 research focused on the analysis of the market and innovation dynamics of Personal Health Systems (PHS), focusing more particularly on the Remote Patient Monitoring and Treatment (RMT) segment of the market.
The reason for focusing on this particular segment was the need for consolidating evidence on the benefits of RMT systems for patients, healthcare professionals and healthcare systems as a whole in light of the perceived potential of RMT to help cope with the challenge of chronic diseases and improve healthcare outcomes (e.g. reducing mortality and hospitalisation). At the same time, the lack of uptake of RMT called for investigating barriers such as market scale constraints, lack of reimbursement, unclear ROI, fragmentation and certification issues which have hampered full deployment of RMT in Europe, not to mention the lack of integration between primary, secondary and social care.

The SIMPHS1 research included desk-research, market data gathering, review and analysis of pilots and projects at EU, national and regional level, in depth country studies and interaction with stakeholders.
The outcomes of SIMPHS1 led to recommendations for policy making in order to foster RMT uptake:

  • provide increased and sustained awareness-raising and dissemination activities, especially focusing on spreading the knowledge about local champions, about the increasing positive evidence of RMT with respect to clinical and cost-effectiveness outcomes, as well as through methodologically robust modelling and simulation of the potential benefits under different take-up scenarios
  • provide further financial support for studies and research aimed at further reinforcing the evidence on outcomes and at moving towards increasingly standardised and accepted evaluation methodologies
  • design innovative mechanisms to support networking and the emergence of hubs among RMT champions and innovators (i.e. creation of centres of excellence for chronic disease management)
  • explore the synergies between eHealth and eInclusion policies and support instruments to bring about health care and social care joined up research and innovation pilots
  • revise the EU value chain of R&D, pilots and validation as to increase the chances of moving to the final stage of sustained service production and delivery
  • leverage the new window of opportunity that may be opened in the post i2020 framework with the envisaged strong investment into broadband ensuring that RMT and more in general PHS are the priority type of services to be supported through these new platforms

In sum, SIMPHS1 showed that if the challenge for European health care systems is to increase the quantity and quality of care in response to higher demand pressures, an answer to this challenge can be effectively provided with the EU-wide deployment of RMT/PHS systems.


Fabienne Abadie